Lineage Cell Therapeutics (LCTX) Total Debt (2014 - 2021)

Lineage Cell Therapeutics' (LCTX) quarterly Total Debt came in at $523000.0 in Q1 2021, little changed quarter-over-quarter from $523000.0 in Q4 2020.

Lineage Cell Therapeutics (LCTX) Total Debt (2014 - 2021) Analysis & Trends

Lineage Cell Therapeutics' Total Debt history runs 6 years deep, the most recent figure standing at $523000.0 for Q1 2021.

  • On a quarterly basis, Total Debt changed N/A year-over-year to $523000.0 in Q1 2021; TTM through Mar 2021 was $523000.0, a N/A change from a year earlier, with the FY2020 full-year figure at $523000.0, changed N/A from the prior year.
  • Total Debt steadied at $523000.0 in Q1 2021 per LCTX's latest filing, from $523000.0 in the prior quarter.
  • Across five years, Total Debt topped out at $523000.0 in Q2 2020 and bottomed at $18000.0 in Q4 2017.
  • The 3-year median for Total Debt is $309000.0 (2017), against an average of $293000.0.
  • Biggest YoY gain for Total Debt was 45.09% in 2017; the steepest drop was 85.0% in 2017.
  • Year by year, Total Debt stood at $18000.0 in 2017, then surged by 2805.56% to $523000.0 in 2020, then changed by 0.0% to $523000.0 in 2021.
  • Per Business Quant, the three latest LCTX Total Debt figures stand at $523000.0 (Q1 2021), $523000.0 (Q4 2020), and $523000.0 (Q3 2020).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 110.96 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 959.06 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 1.99 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Lineage Cell Therapeutics 251.15 Mn 188.44 Mn 1.73 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2021 523,000.00
Dec 31, 2020 523,000.00
Sep 30, 2020 523,000.00
Jun 30, 2020 523,000.00
Dec 31, 2017 18,000.00
Sep 30, 2017 44,000.00
Jun 30, 2017 95,000.00
Mar 31, 2017 95,000.00
Dec 31, 2016 120,000.00
Sep 30, 2016 173,000.00
Jun 30, 2016 173,000.00
Mar 31, 2016 220,000.00
Dec 31, 2015 246,000.00
Sep 30, 2015 268,000.00
Jun 30, 2015 3,000.00
Mar 31, 2015 17,307.00
Dec 31, 2014 31,000.00
Sep 30, 2014 44,963.00
Jun 30, 2014 57,500.00